Copyright
©2013 Baishideng Publishing Group Co.
World J Transplant. Dec 24, 2013; 3(4): 68-77
Published online Dec 24, 2013. doi: 10.5500/wjt.v3.i4.68
Published online Dec 24, 2013. doi: 10.5500/wjt.v3.i4.68
Drug name | Mechanism of action |
Induction | |
Efalizumab1 | Humanized antibody, CD11a/LFA-1 |
Alefacept1 | Costimulation inhibitor, CD2 LFA3 |
Maintenance | |
Voclosporin, ISA247 | Calcineurin inhibitor |
Sotrastaurin, AEB0711 | Protein kinase C inhibitor |
Tofacitinib, CP-6905501 | JAK 3 inhibitor |
ASKP1240 | Anti-CD40 monoclonal antibody |
Treatment of Antibody Medicated Rejection | |
Bortezomib | Proteasome inhibitor |
Eculizumab | Monoclonal antibody, C5 complement protein |
- Citation: Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant 2013; 3(4): 68-77
- URL: https://www.wjgnet.com/2220-3230/full/v3/i4/68.htm
- DOI: https://dx.doi.org/10.5500/wjt.v3.i4.68